Analysis of adverse events with ruxolitinib using real-world datasets and drug-interaction networks by Hideyuki Tanaka, Mika Maezawa, Mizuki Tanaka, Ryogo Umetsu, Sakiko Hirofuji, Koumi Miyasaka, Satoshi Nakao, Yuka Nokura, Moe Yamashita, Nanaka Ichihara, Kana Sugishita, Tomofumi Yamazaki, Kohei Shiota, Hirofumi Tamaki, Kazuhiro Iguchi, Mitsuhiro Nakamura

Get full text